To Evaluate the PK, PD, Safety and Drug Tolerance in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

June 2, 2022

Primary Completion Date

August 26, 2022

Study Completion Date

September 14, 2022

Conditions
Healthy
Interventions
DRUG

Reference Drug or Test Drug

"Test Drug: single administration of JW0301 Reference Drug: single administration of C2105~Tablet, Oral, QD for 1 Days, Washout period is more than 14 days after administration"

Trial Locations (1)

Unknown

Clinical Trial Center, Seoul National University Hospital, Seoul

Sponsors

Lead Sponsor

All Listed Sponsors
lead

JW Pharmaceutical

INDUSTRY